Cargando…

Patient-Derived Cancer Organoids as Predictors of Treatment Response

Patient-derived cancer organoids have taken a prominent role in pre-clinical and translational research and have been generated for most common solid tumors. Cancer organoids have been shown to retain key genetic and phenotypic characteristics of their tissue of origin, tumor subtype and maintain in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verduin, Maikel, Hoeben, Ann, De Ruysscher, Dirk, Vooijs, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012903/ https://www.ncbi.nlm.nih.gov/pubmed/33816288 http://dx.doi.org/10.3389/fonc.2021.641980

Ejemplares similares

Radiation-Induced Lung Injury (RILI)
por: Giuranno, Lorena, et al.
Publicado: (2019)

Artificial Intelligence Applications to Improve the Treatment of Locally Advanced Non-Small Cell Lung Cancers
por: Hope, Andrew, et al.
Publicado: (2021)

Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response
por: Verduin, Maikel, et al.
Publicado: (2018)

Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response
por: Shukla, Hem D, et al.
Publicado: (2023)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions
por: Hartgerink, Dianne, et al.
Publicado: (2018)

Advances of Patient-Derived Organoids in Personalized Radiotherapy
por: Wang, Yuenan, et al.
Publicado: (2022)

Patient-derived rectal cancer organoids—applications in basic and translational cancer research
por: Yan, Yumeng, et al.
Publicado: (2022)

Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
por: Sharick, Joe T., et al.
Publicado: (2020)

Imaging-Based Machine Learning Analysis of Patient-Derived Tumor Organoid Drug Response
por: Spiller, Erin R., et al.
Publicado: (2021)

Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization
por: Lucky, Sasidharan Swarnalatha, et al.
Publicado: (2021)

Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models
por: Tan, Dengxu, et al.
Publicado: (2022)

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
por: Wang, Ji, et al.
Publicado: (2022)

Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
por: Geevimaan, Khamushavalli, et al.
Publicado: (2022)

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
por: Chen, Lifeng, et al.
Publicado: (2022)

Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues
por: Marinucci, Mattia, et al.
Publicado: (2022)

Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
por: Vaes, Rianne D. W., et al.
Publicado: (2021)

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
por: Zhang, Wei, et al.
Publicado: (2023)

Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis
por: Moreno Roig, Eloy, et al.
Publicado: (2018)

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
por: Sosa Iglesias, Venus, et al.
Publicado: (2018)

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
por: Lind, Joline S. W., et al.
Publicado: (2010)

Application of Organoid Models in Prostate Cancer Research
por: Zhou, Ligui, et al.
Publicado: (2021)

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
por: Shu, Dan, et al.
Publicado: (2022)

Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer
por: Wanigasooriya, Kasun, et al.
Publicado: (2022)

The applications and techniques of organoids in head and neck cancer therapy
por: Qi, Hao, et al.
Publicado: (2023)

Patient-Derived Organoid Facilitating Personalized Medicine in Gastrointestinal Stromal Tumor With Liver Metastasis: A Case Report
por: Cao, Ying, et al.
Publicado: (2022)

Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures
por: Wakamatsu, Toru, et al.
Publicado: (2022)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
por: Klein, Eliane, et al.
Publicado: (2020)

Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples
por: Choi, Sun Il, et al.
Publicado: (2019)

Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
por: Sosa Iglesias, Venus, et al.
Publicado: (2018)

Patient-derived organoids facilitating individual therapy in an adolescent with embryonal rhabdomyosarcoma of the cervix: a case report and literature review
por: Qiao, Xinyu, et al.
Publicado: (2023)

Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
por: Wensink, G. Emerens, et al.
Publicado: (2021)

Organoid: Next-Generation Modeling of Cancer Research and Drug Development
por: Liu, Jungang, et al.
Publicado: (2022)

Lung cancer organoids: models for preclinical research and precision medicine
por: Liu, Yajing, et al.
Publicado: (2023)

The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer
por: Su, Chang, et al.
Publicado: (2023)

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zeng, Haiyan, et al.
Publicado: (2022)

Patient-Derived Cancer Organoids for Precision Oncology Treatment
por: Pernik, Mark N., et al.
Publicado: (2021)

Organoids Increase the Predictive Value of in vitro Cancer Chemoprevention Studies for in vivo Outcome
por: Njoroge, Rose N., et al.
Publicado: (2019)

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)
por: Bian, Benjamin, et al.
Publicado: (2019)

A deep learning model for drug screening and evaluation in bladder cancer organoids
por: Zhang, Shudi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_shrl1gpigodh8a1r8jj91l8h9q